Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer
NCT: NCT05804318 · RECRUITING
Brief Summary
This trial is a prospective, single-arm, multi-center clinical trial designed to assess whether adaptive radiotherapy with urethral sparing for low to intermediate risk localized prostate cancer will translate into a decreased rate of patient reported acute urinary side effects, as measured by the patient reported EPIC-26 questionnaire, compared with the historically reported rate for non-adaptive, non-urethral sparing prostate SBRT.
Frequently Asked Questions
What is Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer?
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer is a clinical trial registered under NCT05804318. Current status: RECRUITING.
What is the status of NCT05804318?
The current status of NCT05804318 (Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer) is: RECRUITING.
When did Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer start?
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer started on 2023-04-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.